When drug patents expire, prices drop-but not always for patients. Learn how patients and healthcare systems can prepare for generic and biosimilar transitions to save money and avoid disruptions.
Evergreening lets pharmaceutical companies delay generic drugs with minor patent tweaks, keeping prices high. Learn how it works, who uses it, and why it harms patient access to affordable medicine.